Investment Banking

We harvest the deep expertise of our senior bankers and product specialists to deliver corporate clients impactful strategic advice and flawlessly executed equity and debt financings aimed at helping them outperform.

Cowen is focused on key sectors of the global economy.  Our clients are having a profound impact on the economy and we are proud to lead manage their capital raising efforts and advise them on company-defining M&A transactions.

We help our clients achieve their goals by consistently delivering for them.  We bring clients the best of our professionals’ collective experience, providing holistic capital markets and strategic advice, thought leadership and connectivity to our industry relationships.

Mergers & Acquisitions

Mergers and Acquisitions

Our M&A professionals have demonstrated expertise in sales and divestitures, strategic partnerships, mergers & acquisitions, fairness opinions / valuations, cross border transactions, takeover defense and shareholder activist situations.  We are equally active with private and public companies in key sectors of the US economy.

We leverage our expertise in capital markets to bring clients a tailored solution that facilitates its company-defining M&A transaction.

Latest Transactions

  • Cowen is pleased to announce that Mission Treatment Services, Inc., a leading operator of clinics that provide opioid use disorder treatment in the form of outpatient medication-assisted treatment MAT, has been acquired by Acadia Healthcare Company.
  • Cowen is pleased to announce that Great Hill Partners, LLC., a leading growth-oriented private equity firm, announced that it has completed the sale of Zoom Information, Inc., a leading B2B data provider, to DiscoverOrg, LLC
  • Catalyst is a leading provider of eDiscovery solutions for corporate legal departments and top law firms.



Michael Wildish
Head of Mergers & Acquisitions
D 646 562 1141 

Equity Capital Markets

Our equity capital markets team is experienced in the successful execution of all types of private and public equity offerings including:

  • IPO
  • Follow-on
  • SPACs
  • Confidentially Marketed Public Offering (CMPO)
  • Registered Direct (RD)
  • PIPE
  • Private Placement
  • At-the-Market Offering (ATM)
  • Convertible Bond
  • Other hybrid solutions


Our team has outstanding institutional relationships and proven experience in efficiently managing and positioning stories with the investment community.  We are in daily communication with institutional investors worldwide, providing us with a live pulse on the market.

Our leading equities market share within key sectors of the US economy enables us to have a deep perspective on core investment themes.  In other words, we know what it takes to help our clients achieve their goals.

Latest Transactions

  • Stemline intends to use the net proceeds from this offering for commercial activities of ELZONRIS (formerly SL 401) including clinical trials for additional indications including CMML, MF and other diseases, clinical development of SL 801, SL 701 and potentially SL-901, research and development activities, potential acquisitions and in-licensing and other general corporate purposes.
  • Revance expects to use the net proceeds from this offering for working capital and general corporate purposes, including clinical trial and related expenses, research and development expenses, general and administrative expenses and capital investments.
  • Quotient Limited intends to use net proceeds from this offering, together with its existing cash and cash equivalents, to fund ongoing scale-up / commercialization of the MosaiQ instrument and for general corporate purposes, including capital expenditures and working capital.



Grant Miller
Head of Equity Capital Markets
D 646 562 1164

Leveraged Finance

Our Leveraged Finance team is experienced in every type of debt including:

  • Revolver
  • ABL facilities
  • Secured loan
  • Unsecured debt
  • Mezzanine debt
  • High yield debt
  • Other customized debt solutions


We operate primarily in the private markets and our transactions span the entire capital structure.

Cowen specializes in “solutions financing”, where a customized product is required to address a unique need (e.g. corporate structure issues, dividend recap desires, atypical collateral for a bond, non-call period to support investment horizon, etc.).

Latest Transactions

  • The Company intends to use the net proceeds to support expansion initiatives future acquisitions and general corporate purposes, including working capital requirements.
  • Greenlane is a leading distributor of premium vaporization products and consumption accessories in the United States and has a growing presence in Canada. Greenlanes customers include over 6,400 independent smoke shops and regional retail chain stores, which collectively operate an estimated 8,000 retail locations, and hundreds of licensed cannabis cultivators, processors and dispensaries.
  • used the proceeds for the Tranche One Loans to pay off a loan provided by Arosa Opportunistic Fund LP in the principal amount of $7.8 million plus interest and for working capital purposes



Craig E. Zaph
Head of Debt Capital Markets
D 646 562 1188


The accomplishments of our investment banking team are possible because of the range of our professionals’ experience and the depth of our client relationships. Our senior professionals have decades of experience on Wall Street at bulge and growth-focused firms.